Dashboard
Manage Tickers

ARWR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-arrowhead-pharma-maintains-80-price-target
HC Wainwright & Co. Reiterates Buy on Arro...
10/08/2025 10:20:12

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $80 p...

arrowhead-pharmaceuticals-files-to-begin-phase-12a-trial-for-dual-target-rnai-drug-aro-dimer-pa-aims-to-treat-atherosclerotic-cardiovascular-disease-from-mixed-hyperlipidemia
Arrowhead Pharmaceuticals Files To Begin P...
10/07/2025 11:34:04

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it has filed a request for regulatory clearance to initiate ...

4-biotechnology-stocks-that-outshine-in-momentum-amid-strong-technicals
4 Biotechnology Stocks That Outshine In Mo...
09/29/2025 11:11:04

Four biotechnology stocks have surged into the top 10th percentile for momentum ranking, demonstrating remarkable week-on-week ...

arrowhead-sues-ionis-seeking-declaratory-judgment-on-patent-validity-over-plozasiran-commercialization
Arrowhead Sues Ionis Seeking Declaratory J...
09/11/2025 11:31:48

arrowhead-pharma-files-request-for-regulatory-clearance-to-initiate-phase-12a-clinical-trial-of-aro-mapt-investigational-rnai-therapeutic-for-tauopathies
Arrowhead Pharma Files Request For Regulat...
09/10/2025 11:31:54

 - In preclinical studies presented today at the RNA Leaders USA Congress 2025, investigational ARO-MAPT demonstrated potent an...

hc-wainwright--co-reiterates-buy-on-arrowhead-pharma-maintains-80-price-target
HC Wainwright & Co. Reiterates Buy on Arro...
09/02/2025 16:05:27

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $80 p...

air-lease-ionis-pharmaceuticals-arrowhead-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday
Air Lease, Ionis Pharmaceuticals, Arrowhea...
09/02/2025 14:41:45

Core News & Articles
Arrowhead Pharmaceuticals Inks Global Lice...
09/02/2025 11:32:42

Upon closing, Arrowhead will receive an upfront payment of $200 millionNovartis will receive an exclusive worldwide license to ...

Core News & Articles
Arrowhead Receives $100M Milestone From Sa...
08/13/2025 20:30:04

- Arrowhead has elected to receive approximately $50 million worth of Arrowhead common stock from Sarepta, which will be placed...

chardan-capital-maintains-buy-on-arrowhead-pharma-maintains-60-price-target
Chardan Capital Maintains Buy on Arrowhead...
08/11/2025 11:42:35

Chardan Capital analyst Keay Nakae maintains Arrowhead Pharma (NASDAQ:ARWR) with a Buy and maintains $60 price target.

rbc-capital-maintains-outperform-on-arrowhead-pharma-lowers-price-target-to-38
RBC Capital Maintains Outperform on Arrowh...
08/08/2025 17:20:57

RBC Capital analyst Luca Issi maintains Arrowhead Pharma (NASDAQ:ARWR) with a Outperform and lowers the price target from $4...

arrowhead-pharma-q3-eps-126-misses-089-estimate-sales-27767m-beat-23711m-estimate
Arrowhead Pharma Q3 EPS $(1.26) Misses $(0...
08/07/2025 20:04:13

Arrowhead Pharma (NASDAQ:ARWR) reported quarterly losses of $(1.26) per share which missed the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Core News & Articles
Sanofi To Acquire Rights To Develop, Comme...
08/01/2025 10:42:37

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced the signing of an asset purchase agreement between Sanofi and Vis...

sarepta-therapeutics-surges-over-40-in-tuesday-pre-market-whats-going-on
Sarepta Therapeutics Surges Over 40% In Tu...
07/29/2025 09:41:32

Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug Administ...

fda-probes-death-of-8-year-old-who-received-sareptas-elevidys
FDA Probes Death Of 8-Year-Old Who Receive...
07/28/2025 12:48:23

FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy tr...

Core News & Articles
Arrowhead Pharmaceuticals Earns $100M Mile...
07/28/2025 11:37:03

Arrowhead currently expects to achieve the second enrollment target by the end of 2025, which would trigger an additional $200 ...

Core News & Articles
Arrowhead Scores $100M From Sarepta After ...
07/28/2025 11:35:43

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) today announced that it has earned a $100 million milestone payment from Sarepta ...

sarepta-gets-thumbs-down-from-regulators-regarding-elevidys-gene-therapy
Sarepta Gets Thumbs Down From Regulators R...
07/25/2025 15:09:35

Sarepta and Roche face a regulatory setback as the EMA's CHMP issues a negative opinion on Elevidys for Duchenne muscular d...

ge-vernova-posts-better-than-expected-earnings-joins-thermo-fisher-scientific-lennox-international-general-dynamics-and-other-big-stocks-moving-higher-on-wednesday
GE Vernova Posts Better-Than-Expected Earn...
07/23/2025 15:00:07

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION